Brain Death Clinical Trial
Official title:
"LiverColor": AN ALGORITHM QUANTIFICATION OF LIVER GRAFT STEATOSIS USING MACHINE LEARNING AND COLOR IMAGE PROCESSING
The main goal of this project is to create a machine learning model in order to quantify liver steatosis in liver donor faster, more objective and reliable than histological analysis and surgeons point-of-view.
Status | Recruiting |
Enrollment | 246 |
Est. completion date | December 31, 2023 |
Est. primary completion date | December 31, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A and older |
Eligibility | Inclusion Criteria: - Livers from donor donor brain death with informed consent before inclusion in the study was obtained from all participants or families. Exclusion Criteria: - Age < 18 years old - Donor after cardiac death - Split - Cholestasis due to a biliary obstruction - Total bilirubin levels above 2,5 mg/dL - Glutamic oxaloacetic transaminase (SGOT)/ serum glutamatepyruvate transaminase (SGPT) levels and gamma-glutamyl transaminase (GGT) levels above 400 U/L - Cirrhotic livers |
Country | Name | City | State |
---|---|---|---|
Spain | Concepción Gómez-Gavara | Barcelona |
Lead Sponsor | Collaborator |
---|---|
Hospital Vall d'Hebron |
Spain,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | The main goal of this project is to create a machine learning model in order to quantify liver steatosis in liver donor faster, more objective and reliable than histological analysis and surgeons point-of-view. | Accuracy | 4 weeks | |
Secondary | To build an image dataset to evaluate postransplant liver function. | PDF will be evaluated according to Olthoff criteria | 1 week |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03765814 -
The Anticipated Organ Donation Approach
|
||
Completed |
NCT02581111 -
Naloxone for Optimizing Hypoxemia Of Lung Donors
|
Phase 2/Phase 3 | |
Completed |
NCT00808691 -
Microcirculation and Oxidative Stress in Critical Ill Patients in Surgical Intensive Care Unit
|
N/A | |
Completed |
NCT00998972 -
N-acetyl-cysteine (NAC) and Kidney Graft Function
|
Phase 3 | |
Completed |
NCT04528797 -
Thyroid and Adrenocortical Hormone Replacement in Organ Donors
|
N/A | |
Completed |
NCT03672812 -
The Use of Liraglutide in Brain Death
|
Phase 3 | |
Completed |
NCT04303624 -
Understanding Family Refusal
|
||
Completed |
NCT03098706 -
Therapeutic Hypothermia in "Expanded Criteria" Brain-dead Donors and Kidney-graft Function
|
N/A | |
Not yet recruiting |
NCT04623294 -
Online Noninvasive Assessment of Human Brain Death and Deep Coma by Near-infrared Spectroscopy
|
||
Recruiting |
NCT02102945 -
Special Imaging Technique to Aid in the Diagnosis of Patients in Coma After Cardiac Arrest
|
N/A | |
Completed |
NCT02483273 -
Alterations of Conjunctival Microcirculation in Brain Dead Patients
|
N/A | |
Terminated |
NCT00675272 -
Organ Donation and Hydrocortisone Treatment
|
N/A | |
Completed |
NCT03262896 -
Neurophysiological Examination in Patients With Brain Death
|
||
Not yet recruiting |
NCT06359119 -
Implementation of Apnoea Test for Patients With Suspected Brain Death
|
||
Completed |
NCT03281993 -
Apnea Tests as the Methods of Brain Death Diagnosis.
|
N/A | |
Completed |
NCT03179020 -
Donation Network to Optimize Organ Recovery Study
|
N/A | |
Completed |
NCT05070182 -
Resting Energy Needs in Brain Dead Patients (reSting EneRgy nEeds iN brAin DEad Patients)
|
||
Terminated |
NCT03439995 -
Goal of Open Lung Ventilation in Donors
|
N/A | |
Completed |
NCT02525510 -
Deceased Organ Donor Interventions to Protect Kidney Graft Function
|
N/A | |
Completed |
NCT02742857 -
Non-randomized, Open-labeled, Interventional, Single Group, Proof of Concept Study With Multi-modality Approach in Cases of Brain Death Due to Traumatic Brain Injury Having Diffuse Axonal Injury
|
Phase 1 |